Your search resulted in multiple matches. Please select a position:

Gencode Genes

SLC2A4 (ENST00000317370.13) at chr17:7281718-7288257 - Homo sapiens solute carrier family 2 member 4 (SLC2A4), mRNA. (from RefSeq NM_001042)
SLC2A4 (ENST00000572485.5) at chr17:7281735-7287833 - Insulin-regulated facilitative glucose transporter. (from UniProt P14672)
SLC2A4 (ENST00000571308.5) at chr17:7281736-7286151 - Belongs to the major facilitator superfamily. Sugar  transporter (TC 2.A.1.1) family. (from UniProt I3L2R4)
SLC2A4 (ENST00000570783.5) at chr17:7281808-7286901 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt I3L1S2)
SLC2A4 (ENST00000424875.2) at chr17:7282130-7286167 - Belongs to the major facilitator superfamily. Sugar  transporter (TC 2.A.1.1) family. (from UniProt F5H081)
TRARG1 (ENST00000626647.1) at chr17_KI270862v1_alt:240276-243012 - trafficking regulator of GLUT4 (SLC2A4) 1 (from HGNC TRARG1)
ASPSCR1 (ENST00000306739.9) at chr17:81977629-82017406 - Homo sapiens ASPSCR1 tether for SLC2A4, UBX domain containing (ASPSCR1), transcript variant 1, mRNA. (from RefSeq NM_024083)
ASPSCR1 (ENST00000580534.5) at chr17:81977634-82017404 - Homo sapiens ASPSCR1 tether for SLC2A4, UBX domain containing (ASPSCR1), transcript variant 3, non-coding RNA. (from RefSeq NR_045351)
ASPSCR1 (ENST00000306729.11) at chr17:81977550-82017404 - Homo sapiens ASPSCR1 tether for SLC2A4, UBX domain containing (ASPSCR1), transcript variant 2, mRNA. (from RefSeq NM_001251888)
TRARG1 (ENST00000333813.4) at chr17:1279662-1300978 - Homo sapiens trafficking regulator of GLUT4 (SLC2A4) 1 (TRARG1), mRNA. (from RefSeq NM_172367)
ASPSCR1 (ENST00000585274.1) at chr17:82009486-82017369 - ASPSCR1, UBX domain containing tether for SLC2A4 (from HGNC ASPSCR1)
ASPSCR1 (ENST00000585140.1) at chr17:82016194-82017370 - ASPSCR1, UBX domain containing tether for SLC2A4 (from HGNC ASPSCR1)
ASPSCR1 (ENST00000583693.5) at chr17:82013234-82017404 - ASPSCR1, UBX domain containing tether for SLC2A4 (from HGNC ASPSCR1)
ASPSCR1 (ENST00000583142.5) at chr17:82012882-82017401 - ASPSCR1, UBX domain containing tether for SLC2A4 (from HGNC ASPSCR1)
ASPSCR1 (ENST00000582404.5) at chr17:82015214-82017404 - ASPSCR1, UBX domain containing tether for SLC2A4 (from HGNC ASPSCR1)
ASPSCR1 (ENST00000582019.5) at chr17:81977899-81983626 - ASPSCR1, UBX domain containing tether for SLC2A4 (from HGNC ASPSCR1)
ASPSCR1 (ENST00000581608.5) at chr17:82007435-82017403 - ASPSCR1, UBX domain containing tether for SLC2A4 (from HGNC ASPSCR1)
ASPSCR1 (ENST00000578361.5) at chr17:82012084-82017403 - ASPSCR1, UBX domain containing tether for SLC2A4 (from HGNC ASPSCR1)
ASPSCR1 (ENST00000578236.5) at chr17:82006642-82017404 - ASPSCR1, UBX domain containing tether for SLC2A4 (from HGNC ASPSCR1)
ASPSCR1 (ENST00000577733.5) at chr17:82004345-82017404 - ASPSCR1, UBX domain containing tether for SLC2A4 (from HGNC ASPSCR1)
FGF21 (ENST00000222157.5) at chr19:48756087-48758333 - Stimulates glucose uptake in differentiated adipocytes  via the induction of glucose transporter SLC2A1/GLUT1 expression  (but not SLC2A4/GLUT4 expression). Activity requires the presence  of KLB. (from UniProt Q9NSA1)
STXBP4 (ENST00000398391.6) at chr17:54968795-55044776 - Plays a role in the translocation of transport vesicles  from the cytoplasm to the plasma membrane. Inhibits the  translocation of SLC2A4 from intracellular vesicles to the plasma  membrane by STX4A binding and preventing the interaction between  STX4A and VAMP2. Stimulation with insulin disrupts the interaction  with STX4A, leading to increased levels of SLC2A4 at the plasma  membrane. May also play a role in the regulation of insulin  release by pancreatic beta cells after stimulation by glucose (By  similarity). (from UniProt Q6ZWJ1)
STXBP4 (ENST00000376352.6) at chr17:54968765-55173632 - Homo sapiens syntaxin binding protein 4 (STXBP4), mRNA. (from RefSeq NM_178509)
STX4 (ENST00000394998.5) at chr16:31033095-31040163 - Homo sapiens syntaxin 4 (STX4), transcript variant 2, mRNA. (from RefSeq NM_001272096)
STX4 (ENST00000313843.8) at chr16:31033558-31040164 - Homo sapiens syntaxin 4 (STX4), transcript variant 3, mRNA. (from RefSeq NM_004604)
SRFBP1 (ENST00000339397.5) at chr5:121961975-122028633 - Homo sapiens serum response factor binding protein 1 (SRFBP1), mRNA. (from RefSeq NM_152546)
DENND4C (ENST00000602925.5) at chr9:19230435-19372858 - Homo sapiens DENN domain containing 4C (DENND4C), transcript variant 1, mRNA. (from RefSeq NM_017925)
DENND4C (ENST00000434457.6) at chr9:19230435-19372598 - Homo sapiens DENN domain containing 4C (DENND4C), transcript variant 2, non-coding RNA. (from RefSeq NR_073201)
ACAP1 (ENST00000158762.8) at chr17:7336529-7351477 - Homo sapiens ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 (ACAP1), mRNA. (from RefSeq NM_014716)
AKT1 (ENST00000649815.1) at chr14:104769371-104795555 - AKT1 is one of 3 closely related serine/threonine-  protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and  which regulate many processes including metabolism, proliferation,  cell survival, growth and angiogenesis. This is mediated through  serine and/or threonine phosphorylation of a range of downstream  substrates. Over 100 substrate candidates have been reported so  far, but for most of them, no isoform specificity has been  reported. AKT is responsible of the regulation of glucose uptake  by mediating insulin-induced translocation of the SLC2A4/GLUT4  glucose transporter to the cell surface. Phosphorylation of PTPN1  at 'Ser-50' negatively modulates its phosphatase activity  preventing dephosphorylation of the insulin receptor and the  attenuation of insulin signaling. Phosphorylation of TBC1D4  triggers the binding of this effector to inhibitory 14-3-3  proteins, which is required for insulin-stimulated glucose  transport. AKT regulates also the storage of glucose in the form  of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at  'Ser-9', resulting in inhibition of its kinase activity.  Phosphorylation of GSK3 isoforms by AKT is also thought to be one  mechanism by which cell proliferation is driven. AKT regulates  also cell survival via the phosphorylation of MAP3K5 (apoptosis  signal-related kinase). Phosphorylation of 'Ser-83' decreases  MAP3K5 kinase activity stimulated by oxidative stress and thereby  prevents apoptosis. AKT mediates insulin-stimulated protein  synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462',  thereby activating mTORC1 signaling and leading to both  phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is  involved in the phosphorylation of members of the FOXO factors  (Forkhead family of transcription factors), leading to binding of  14-3-3 proteins and cytoplasmic localization. In particular, FOXO1  is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and  FOXO4 are phosphorylated on equivalent sites. AKT has an important  role in the regulation of NF-kappa-B-dependent gene transcription  and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-  response element binding protein). The phosphorylation of CREB1  induces the binding of accessory proteins that are necessary for  the transcription of pro-survival genes such as BCL2 and MCL1. AKT  phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby  potentially regulating ACLY activity and fatty acid synthesis.  Activates the 3B isoform of cyclic nucleotide phosphodiesterase  (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced  cyclic AMP levels and inhibition of lipolysis. Phosphorylates  PIKFYVE on 'Ser-318', which results in increased PI(3)P-5  activity. The Rho GTPase-activating protein DLC1 is another  substrate and its phosphorylation is implicated in the regulation  cell proliferation and cell growth. AKT plays a role as key  modulator of the AKT-mTOR signaling pathway controlling the tempo  of the process of newborn neurons integration during adult  neurogenesis, including correct neuron positioning, dendritic  development and synapse formation. Signals downstream of  phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of  various growth factors such as platelet-derived growth factor  (PDGF), epidermal growth factor (EGF), insulin and insulin-like  growth factor I (IGF-I). AKT mediates the antiapoptotic effects of  IGF-I. Essential for the SPATA13-mediated regulation of cell  migration and adhesion assembly and disassembly. May be involved  in the regulation of the placental development. Phosphorylates  STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its:  kinase activity, nuclear translocation, autophosphorylation and  ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-  117' and 'Thr-384' leading to inhibition of its: cleavage, kinase  activity, autophosphorylation at Thr-180, binding to RASSF1 and  nuclear translocation. Phosphorylates SRPK2 and enhances its  kinase activity towards SRSF2 and ACIN1 and promotes its nuclear  translocation. Phosphorylates RAF1 at 'Ser-259' and negatively  regulates its activity. Phosphorylation of BAD stimulates its pro-  apoptotic activity. (from UniProt P31749)
AKT1 (ENST00000554848.5) at chr14:104770341-104794191 - AKT1 is one of 3 closely related serine/threonine-  protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and  which regulate many processes including metabolism, proliferation,  cell survival, growth and angiogenesis. This is mediated through  serine and/or threonine phosphorylation of a range of downstream  substrates. Over 100 substrate candidates have been reported so  far, but for most of them, no isoform specificity has been  reported. AKT is responsible of the regulation of glucose uptake  by mediating insulin-induced translocation of the SLC2A4/GLUT4  glucose transporter to the cell surface. Phosphorylation of PTPN1  at 'Ser-50' negatively modulates its phosphatase activity  preventing dephosphorylation of the insulin receptor and the  attenuation of insulin signaling. Phosphorylation of TBC1D4  triggers the binding of this effector to inhibitory 14-3-3  proteins, which is required for insulin-stimulated glucose  transport. AKT regulates also the storage of glucose in the form  of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at  'Ser-9', resulting in inhibition of its kinase activity.  Phosphorylation of GSK3 isoforms by AKT is also thought to be one  mechanism by which cell proliferation is driven. AKT regulates  also cell survival via the phosphorylation of MAP3K5 (apoptosis  signal-related kinase). Phosphorylation of 'Ser-83' decreases  MAP3K5 kinase activity stimulated by oxidative stress and thereby  prevents apoptosis. AKT mediates insulin-stimulated protein  synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462',  thereby activating mTORC1 signaling and leading to both  phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is  involved in the phosphorylation of members of the FOXO factors  (Forkhead family of transcription factors), leading to binding of  14-3-3 proteins and cytoplasmic localization. In particular, FOXO1  is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and  FOXO4 are phosphorylated on equivalent sites. AKT has an important  role in the regulation of NF-kappa-B-dependent gene transcription  and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-  response element binding protein). The phosphorylation of CREB1  induces the binding of accessory proteins that are necessary for  the transcription of pro-survival genes such as BCL2 and MCL1. AKT  phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby  potentially regulating ACLY activity and fatty acid synthesis.  Activates the 3B isoform of cyclic nucleotide phosphodiesterase  (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced  cyclic AMP levels and inhibition of lipolysis. Phosphorylates  PIKFYVE on 'Ser-318', which results in increased PI(3)P-5  activity. The Rho GTPase-activating protein DLC1 is another  substrate and its phosphorylation is implicated in the regulation  cell proliferation and cell growth. AKT plays a role as key  modulator of the AKT-mTOR signaling pathway controlling the tempo  of the process of newborn neurons integration during adult  neurogenesis, including correct neuron positioning, dendritic  development and synapse formation. Signals downstream of  phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of  various growth factors such as platelet-derived growth factor  (PDGF), epidermal growth factor (EGF), insulin and insulin-like  growth factor I (IGF-I). AKT mediates the antiapoptotic effects of  IGF-I. Essential for the SPATA13-mediated regulation of cell  migration and adhesion assembly and disassembly. May be involved  in the regulation of the placental development. Phosphorylates  STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its:  kinase activity, nuclear translocation, autophosphorylation and  ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-  117' and 'Thr-384' leading to inhibition of its: cleavage, kinase  activity, autophosphorylation at Thr-180, binding to RASSF1 and  nuclear translocation. Phosphorylates SRPK2 and enhances its  kinase activity towards SRSF2 and ACIN1 and promotes its nuclear  translocation. Phosphorylates RAF1 at 'Ser-259' and negatively  regulates its activity. Phosphorylation of BAD stimulates its pro-  apoptotic activity. (from UniProt P31749)
AKT1 (ENST00000554581.5) at chr14:104769349-104794124 - AKT1 is one of 3 closely related serine/threonine-  protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and  which regulate many processes including metabolism, proliferation,  cell survival, growth and angiogenesis. This is mediated through  serine and/or threonine phosphorylation of a range of downstream  substrates. Over 100 substrate candidates have been reported so  far, but for most of them, no isoform specificity has been  reported. AKT is responsible of the regulation of glucose uptake  by mediating insulin-induced translocation of the SLC2A4/GLUT4  glucose transporter to the cell surface. Phosphorylation of PTPN1  at 'Ser-50' negatively modulates its phosphatase activity  preventing dephosphorylation of the insulin receptor and the  attenuation of insulin signaling. Phosphorylation of TBC1D4  triggers the binding of this effector to inhibitory 14-3-3  proteins, which is required for insulin-stimulated glucose  transport. AKT regulates also the storage of glucose in the form  of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at  'Ser-9', resulting in inhibition of its kinase activity.  Phosphorylation of GSK3 isoforms by AKT is also thought to be one  mechanism by which cell proliferation is driven. AKT regulates  also cell survival via the phosphorylation of MAP3K5 (apoptosis  signal-related kinase). Phosphorylation of 'Ser-83' decreases  MAP3K5 kinase activity stimulated by oxidative stress and thereby  prevents apoptosis. AKT mediates insulin-stimulated protein  synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462',  thereby activating mTORC1 signaling and leading to both  phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is  involved in the phosphorylation of members of the FOXO factors  (Forkhead family of transcription factors), leading to binding of  14-3-3 proteins and cytoplasmic localization. In particular, FOXO1  is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and  FOXO4 are phosphorylated on equivalent sites. AKT has an important  role in the regulation of NF-kappa-B-dependent gene transcription  and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-  response element binding protein). The phosphorylation of CREB1  induces the binding of accessory proteins that are necessary for  the transcription of pro-survival genes such as BCL2 and MCL1. AKT  phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby  potentially regulating ACLY activity and fatty acid synthesis.  Activates the 3B isoform of cyclic nucleotide phosphodiesterase  (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced  cyclic AMP levels and inhibition of lipolysis. Phosphorylates  PIKFYVE on 'Ser-318', which results in increased PI(3)P-5  activity. The Rho GTPase-activating protein DLC1 is another  substrate and its phosphorylation is implicated in the regulation  cell proliferation and cell growth. AKT plays a role as key  modulator of the AKT-mTOR signaling pathway controlling the tempo  of the process of newborn neurons integration during adult  neurogenesis, including correct neuron positioning, dendritic  development and synapse formation. Signals downstream of  phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of  various growth factors such as platelet-derived growth factor  (PDGF), epidermal growth factor (EGF), insulin and insulin-like  growth factor I (IGF-I). AKT mediates the antiapoptotic effects of  IGF-I. Essential for the SPATA13-mediated regulation of cell  migration and adhesion assembly and disassembly. May be involved  in the regulation of the placental development. Phosphorylates  STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its:  kinase activity, nuclear translocation, autophosphorylation and  ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-  117' and 'Thr-384' leading to inhibition of its: cleavage, kinase  activity, autophosphorylation at Thr-180, binding to RASSF1 and  nuclear translocation. Phosphorylates SRPK2 and enhances its  kinase activity towards SRSF2 and ACIN1 and promotes its nuclear  translocation. Phosphorylates RAF1 at 'Ser-259' and negatively  regulates its activity. Phosphorylation of BAD stimulates its pro-  apoptotic activity. (from UniProt P31749)
AKT1 (ENST00000402615.6) at chr14:104769352-104794528 - AKT1 is one of 3 closely related serine/threonine-  protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and  which regulate many processes including metabolism, proliferation,  cell survival, growth and angiogenesis. This is mediated through  serine and/or threonine phosphorylation of a range of downstream  substrates. Over 100 substrate candidates have been reported so  far, but for most of them, no isoform specificity has been  reported. AKT is responsible of the regulation of glucose uptake  by mediating insulin-induced translocation of the SLC2A4/GLUT4  glucose transporter to the cell surface. Phosphorylation of PTPN1  at 'Ser-50' negatively modulates its phosphatase activity  preventing dephosphorylation of the insulin receptor and the  attenuation of insulin signaling. Phosphorylation of TBC1D4  triggers the binding of this effector to inhibitory 14-3-3  proteins, which is required for insulin-stimulated glucose  transport. AKT regulates also the storage of glucose in the form  of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at  'Ser-9', resulting in inhibition of its kinase activity.  Phosphorylation of GSK3 isoforms by AKT is also thought to be one  mechanism by which cell proliferation is driven. AKT regulates  also cell survival via the phosphorylation of MAP3K5 (apoptosis  signal-related kinase). Phosphorylation of 'Ser-83' decreases  MAP3K5 kinase activity stimulated by oxidative stress and thereby  prevents apoptosis. AKT mediates insulin-stimulated protein  synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462',  thereby activating mTORC1 signaling and leading to both  phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is  involved in the phosphorylation of members of the FOXO factors  (Forkhead family of transcription factors), leading to binding of  14-3-3 proteins and cytoplasmic localization. In particular, FOXO1  is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and  FOXO4 are phosphorylated on equivalent sites. AKT has an important  role in the regulation of NF-kappa-B-dependent gene transcription  and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-  response element binding protein). The phosphorylation of CREB1  induces the binding of accessory proteins that are necessary for  the transcription of pro-survival genes such as BCL2 and MCL1. AKT  phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby  potentially regulating ACLY activity and fatty acid synthesis.  Activates the 3B isoform of cyclic nucleotide phosphodiesterase  (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced  cyclic AMP levels and inhibition of lipolysis. Phosphorylates  PIKFYVE on 'Ser-318', which results in increased PI(3)P-5  activity. The Rho GTPase-activating protein DLC1 is another  substrate and its phosphorylation is implicated in the regulation  cell proliferation and cell growth. AKT plays a role as key  modulator of the AKT-mTOR signaling pathway controlling the tempo  of the process of newborn neurons integration during adult  neurogenesis, including correct neuron positioning, dendritic  development and synapse formation. Signals downstream of  phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of  various growth factors such as platelet-derived growth factor  (PDGF), epidermal growth factor (EGF), insulin and insulin-like  growth factor I (IGF-I). AKT mediates the antiapoptotic effects of  IGF-I. Essential for the SPATA13-mediated regulation of cell  migration and adhesion assembly and disassembly. May be involved  in the regulation of the placental development. Phosphorylates  STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its:  kinase activity, nuclear translocation, autophosphorylation and  ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-  117' and 'Thr-384' leading to inhibition of its: cleavage, kinase  activity, autophosphorylation at Thr-180, binding to RASSF1 and  nuclear translocation. Phosphorylates SRPK2 and enhances its  kinase activity towards SRSF2 and ACIN1 and promotes its nuclear  translocation. Phosphorylates RAF1 at 'Ser-259' and negatively  regulates its activity. Phosphorylation of BAD stimulates its pro-  apoptotic activity. (from UniProt P31749)
AKT2 (ENST00000311278.10) at chr19:40233841-40265312 - AKT2 is one of 3 closely related serine/threonine-  protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and  which regulate many processes including metabolism, proliferation,  cell survival, growth and angiogenesis. This is mediated through  serine and/or threonine phosphorylation of a range of downstream  substrates. Over 100 substrate candidates have been reported so  far, but for most of them, no isoform specificity has been  reported. AKT is responsible of the regulation of glucose uptake  by mediating insulin-induced translocation of the SLC2A4/GLUT4  glucose transporter to the cell surface. Phosphorylation of PTPN1  at 'Ser-50' negatively modulates its phosphatase activity  preventing dephosphorylation of the insulin receptor and the  attenuation of insulin signaling. Phosphorylation of TBC1D4  triggers the binding of this effector to inhibitory 14-3-3  proteins, which is required for insulin-stimulated glucose  transport. AKT regulates also the storage of glucose in the form  of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at  'Ser-9', resulting in inhibition of its kinase activity.  Phosphorylation of GSK3 isoforms by AKT is also thought to be one  mechanism by which cell proliferation is driven. AKT regulates  also cell survival via the phosphorylation of MAP3K5 (apoptosis  signal-related kinase). Phosphorylation of 'Ser-83' decreases  MAP3K5 kinase activity stimulated by oxidative stress and thereby  prevents apoptosis. AKT mediates insulin-stimulated protein  synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462',  thereby activating mTORC1 signaling and leading to both  phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is  involved in the phosphorylation of members of the FOXO factors  (Forkhead family of transcription factors), leading to binding of  14-3-3 proteins and cytoplasmic localization. In particular, FOXO1  is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and  FOXO4 are phosphorylated on equivalent sites. AKT has an important  role in the regulation of NF-kappa-B-dependent gene transcription  and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-  response element binding protein). The phosphorylation of CREB1  induces the binding of accessory proteins that are necessary for  the transcription of pro-survival genes such as BCL2 and MCL1. AKT  phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby  potentially regulating ACLY activity and fatty acid synthesis.  Activates the 3B isoform of cyclic nucleotide phosphodiesterase  (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced  cyclic AMP levels and inhibition of lipolysis. Phosphorylates  PIKFYVE on 'Ser-318', which results in increased PI(3)P-5  activity. The Rho GTPase-activating protein DLC1 is another  substrate and its phosphorylation is implicated in the regulation  cell proliferation and cell growth. AKT plays a role as key  modulator of the AKT-mTOR signaling pathway controlling the tempo  of the process of newborn neurons integration during adult  neurogenesis, including correct neuron positioning, dendritic  development and synapse formation. Signals downstream of  phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of  various growth factors such as platelet-derived growth factor  (PDGF), epidermal growth factor (EGF), insulin and insulin-like  growth factor I (IGF-I). AKT mediates the antiapoptotic effects of  IGF-I. Essential for the SPATA13-mediated regulation of cell  migration and adhesion assembly and disassembly. May be involved  in the regulation of the placental development. (from UniProt P31751)
TNKS2 (ENST00000371627.5) at chr10:91798426-91865475 - Homo sapiens tankyrase 2 (TNKS2), mRNA. (from RefSeq NM_025235)
TNKS (ENST00000310430.11) at chr8:9555912-9782346 - Homo sapiens tankyrase (TNKS), mRNA. (from RefSeq NM_003747)
TBC1D1 (ENST00000508802.5) at chr4:37891087-38137619 - Homo sapiens TBC1 domain family member 1 (TBC1D1), transcript variant 2, mRNA. (from RefSeq NM_001253912)
TBC1D1 (ENST00000261439.9) at chr4:37891084-38139173 - Homo sapiens TBC1 domain family member 1 (TBC1D1), transcript variant 1, mRNA. (from RefSeq NM_015173)
PEA15 (ENST00000360472.8) at chr1:160205337-160215376 - Homo sapiens proliferation and apoptosis adaptor protein 15 (PEA15), transcript variant 2, mRNA. (from RefSeq NM_003768)
PEA15 (ENST00000368076.1) at chr1:160205421-160215376 - Homo sapiens proliferation and apoptosis adaptor protein 15 (PEA15), transcript variant 1, mRNA. (from RefSeq NM_001297576)
EXOC7 (ENST00000634349.1) at chr17:76083648-76103692 - Homo sapiens exocyst complex component 7 (EXOC7), transcript variant 6, mRNA. (from RefSeq NM_001145299)
EXOC7 (ENST00000411744.6) at chr17:76083648-76103692 - Homo sapiens exocyst complex component 7 (EXOC7), transcript variant 5, mRNA. (from RefSeq NM_001145298)
EXOC7 (ENST00000332065.9) at chr17:76081017-76103695 - Homo sapiens exocyst complex component 7 (EXOC7), transcript variant 2, mRNA. (from RefSeq NM_015219)
EXOC7 (ENST00000335146.11) at chr17:76082391-76103746 - Homo sapiens exocyst complex component 7 (EXOC7), transcript variant 4, mRNA. (from RefSeq NM_001145297)
EXOC7 (ENST00000589210.6) at chr17:76081016-76103787 - Homo sapiens exocyst complex component 7 (EXOC7), transcript variant 1, mRNA. (from RefSeq NM_001013839)
FGF21 (ENST00000593756.6) at chr19:48755524-48758330 - Homo sapiens fibroblast growth factor 21 (FGF21), mRNA. (from RefSeq NM_019113)
AKT2 (ENST00000392038.7) at chr19:40230317-40285345 - Homo sapiens AKT serine/threonine kinase 2 (AKT2), transcript variant 1, mRNA. (from RefSeq NM_001626)
SORT1 (ENST00000538502.5) at chr1:109309568-109393357 - Homo sapiens sortilin 1 (SORT1), transcript variant 2, mRNA. (from RefSeq NM_001205228)
SORT1 (ENST00000256637.8) at chr1:109309575-109397918 - Homo sapiens sortilin 1 (SORT1), transcript variant 1, mRNA. (from RefSeq NM_002959)
RAB10 (ENST00000264710.5) at chr2:26034084-26137454 - Homo sapiens RAB10, member RAS oncogene family (RAB10), mRNA. (from RefSeq NM_016131)
MYO5A (ENST00000399231.7) at chr15:52307283-52529050 - Homo sapiens myosin VA (MYO5A), transcript variant 1, mRNA. (from RefSeq NM_000259)
MYO5A (ENST00000356338.10) at chr15:52307286-52528880 - Homo sapiens myosin VA (MYO5A), transcript variant 2, mRNA. (from RefSeq NM_001142495)
NDUFA9 (ENST00000266544.10) at chr12:4649114-4694317 - Homo sapiens NADH:ubiquinone oxidoreductase subunit A9 (NDUFA9), mRNA. (from RefSeq NM_005002)
AKT1 (ENST00000555528.5) at chr14:104769371-104793700 - Homo sapiens AKT serine/threonine kinase 1 (AKT1), transcript variant 1, mRNA. (from RefSeq NM_005163)
AKT1 (ENST00000349310.7) at chr14:104769349-104795751 - Homo sapiens AKT serine/threonine kinase 1 (AKT1), transcript variant 2, mRNA. (from RefSeq NM_001014432)
AKT1 (ENST00000407796.6) at chr14:104769349-104795679 - Homo sapiens AKT serine/threonine kinase 1 (AKT1), transcript variant 3, mRNA. (from RefSeq NM_001014431)
TBC1D4 (ENST00000377636.8) at chr13:75283503-75482169 - Homo sapiens TBC1 domain family member 4 (TBC1D4), transcript variant 1, mRNA. (from RefSeq NM_014832)
TBC1D4 (ENST00000431480.6) at chr13:75284665-75482114 - Homo sapiens TBC1 domain family member 4 (TBC1D4), transcript variant 2, mRNA. (from RefSeq NM_001286658)
TBC1D4 (ENST00000377625.6) at chr13:75284665-75482114 - Homo sapiens TBC1 domain family member 4 (TBC1D4), transcript variant 3, mRNA. (from RefSeq NM_001286659)
PRKCZ (ENST00000461106.6) at chr1:2073986-2185190 - Homo sapiens protein kinase C zeta (PRKCZ), transcript variant 4, mRNA. (from RefSeq NM_001242874)
PRKCZ (ENST00000378567.8) at chr1:2050411-2185395 - Homo sapiens protein kinase C zeta (PRKCZ), transcript variant 1, mRNA. (from RefSeq NM_002744)
PIK3C2A (ENST00000265970.11) at chr11:17086572-17169741 - Homo sapiens phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha (PIK3C2A), transcript variant 1, mRNA. (from RefSeq NM_002645)
AKT2 (ENST00000424901.5) at chr19:40230318-40285395 - Homo sapiens AKT serine/threonine kinase 2 (AKT2), transcript variant 4, mRNA. (from RefSeq NM_001330511)
PRKAA1 (ENST00000397128.6) at chr5:40759379-40798198 - Homo sapiens protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), transcript variant 1, mRNA. (from RefSeq NM_006251)
PRKAA1 (ENST00000354209.7) at chr5:40762770-40798374 - Homo sapiens protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), transcript variant 2, mRNA. (from RefSeq NM_206907)
SGK1 (ENST00000367857.9) at chr6:134169353-134174865 - Serine/threonine-protein kinase which is involved in the  regulation of a wide variety of ion channels, membrane  transporters, cellular enzymes, transcription factors, neuronal  excitability, cell growth, proliferation, survival, migration and  apoptosis. Plays an important role in cellular stress response.  Contributes to regulation of renal Na(+) retention, renal K(+)  elimination, salt appetite, gastric acid secretion, intestinal  Na(+)/H(+) exchange and nutrient transport, insulin-dependent salt  sensitivity of blood pressure, salt sensitivity of peripheral  glucose uptake, cardiac repolarization and memory consolidation.  Up-regulates Na(+) channels: SCNN1A/ENAC, SCN5A and ASIC1/ACCN2,  K(+) channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and KCNE1, epithelial  Ca(2+) channels: TRPV5 and TRPV6, chloride channels: BSND, CLCN2  and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2 /EAAT2,  SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid  transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine  transporter: SLC6A8, Na(+)/dicarboxylate cotransporter:  SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter:  SLC34A2/NAPI-2B, glutamate receptor: GRIK2/GLUR6. Up-regulates  carriers: SLC9A3/NHE3, SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT,  SLC2A1/GLUT1, SLC5A1/SGLT1 and SLC15A2/PEPT2. Regulates enzymes:  GSK3A/B, PMM2 and Na(+)/K(+) ATPase, and transcription factors:  CTNNB1 and nuclear factor NF-kappa-B. Stimulates sodium transport  into epithelial cells by enhancing the stability and expression of  SCNN1A/ENAC. This is achieved by phosphorylating the NEDD4L  ubiquitin E3 ligase, promoting its interaction with 14-3-3  proteins, thereby preventing it from binding to SCNN1A/ENAC and  targeting it for degradation. Regulates store-operated Ca(+2)  entry (SOCE) by stimulating ORAI1 and STIM1. Regulates KCNJ1/ROMK1  directly via its phosphorylation or indirectly via increased  interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and  activates MDM2-dependent ubiquitination of p53/TP53.  Phosphorylates MAPT/TAU and mediates microtubule depolymerization  and neurite formation in hippocampal neurons. Phosphorylates  SLC2A4/GLUT4 and up-regulates its activity. Phosphorylates  APBB1/FE65 and promotes its localization to the nucleus.  Phosphorylates MAPK1/ERK2 and activates it by enhancing its  interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Phosphorylates FBXW7  and plays an inhibitory role in the NOTCH1 signaling.  Phosphorylates FOXO1 resulting in its relocalization from the  nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit  from the nucleus and interference with FOXO3-dependent  transcription. Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits  their activity. Phosphorylates SLC9A3/NHE3 in response to  dexamethasone, resulting in its activation and increased  localization at the cell membrane. Phosphorylates CREB1. Necessary  for vascular remodeling during angiogenesis. Sustained high levels  and activity may contribute to conditions such as hypertension and  diabetic nephropathy. Isoform 2 exhibited a greater effect on cell  plasma membrane expression of SCNN1A/ENAC and Na(+) transport than  isoform 1. (from UniProt O00141)
MAPK12 (ENST00000622558.4) at chr22:50252903-50261716 - Homo sapiens mitogen-activated protein kinase 12 (MAPK12), transcript variant 2, mRNA. (from RefSeq NM_001303252)
MAPK12 (ENST00000215659.13) at chr22:50252901-50261683 - Homo sapiens mitogen-activated protein kinase 12 (MAPK12), transcript variant 1, mRNA. (from RefSeq NM_002969)
PRKCZ (ENST00000400921.6) at chr1:2073462-2185390 - Homo sapiens protein kinase C zeta (PRKCZ), transcript variant 9, non-coding RNA. (from RefSeq NR_146911)
INSR (ENST00000341500.9) at chr19:7112255-7293931 - Homo sapiens insulin receptor (INSR), transcript variant 2, mRNA. (from RefSeq NM_001079817)
INSR (ENST00000302850.10) at chr19:7112265-7294414 - Homo sapiens insulin receptor (INSR), transcript variant 1, mRNA. (from RefSeq NM_000208)
DAXX (ENST00000445009.6) at chr6_GL000254v2_alt:4754493-4758881 - Homo sapiens death domain associated protein (DAXX), transcript variant 2, mRNA. (from RefSeq NM_001350)
DAXX (ENST00000399344.7) at chr6_GL000255v2_alt:4512987-4517440 - Homo sapiens death domain associated protein (DAXX), transcript variant 2, mRNA. (from RefSeq NM_001350)
DAXX (ENST00000414083.6) at chr6:33318559-33323016 - Homo sapiens death domain associated protein (DAXX), transcript variant 4, mRNA. (from RefSeq NM_001254717)
DAXX (ENST00000612868.4) at chr6_GL000251v2_alt:4730044-4734505 - Homo sapiens death domain associated protein (DAXX), transcript variant 4, mRNA. (from RefSeq NM_001254717)
DAXX (ENST00000455860.6) at chr6_GL000251v2_alt:4730043-4734499 - Homo sapiens death domain associated protein (DAXX), transcript variant 2, mRNA. (from RefSeq NM_001350)
DAXX (ENST00000612888.2) at chr6_GL000252v2_alt:4562074-4566535 - Homo sapiens death domain associated protein (DAXX), transcript variant 4, mRNA. (from RefSeq NM_001254717)
DAXX (ENST00000399060.7) at chr6_GL000252v2_alt:4562073-4566529 - Homo sapiens death domain associated protein (DAXX), transcript variant 2, mRNA. (from RefSeq NM_001350)
DAXX (ENST00000617660.4) at chr6_GL000255v2_alt:4512988-4517446 - Homo sapiens death domain associated protein (DAXX), transcript variant 4, mRNA. (from RefSeq NM_001254717)
DAXX (ENST00000374542.10) at chr6:33318558-33322959 - Homo sapiens death domain associated protein (DAXX), transcript variant 2, mRNA. (from RefSeq NM_001350)
PRKAA2 (ENST00000371244.9) at chr1:56645314-56715335 - Homo sapiens protein kinase AMP-activated catalytic subunit alpha 2 (PRKAA2), mRNA. (from RefSeq NM_006252)
SGK1 (ENST00000528577.5) at chr6:134169881-134177905 - Homo sapiens serum/glucocorticoid regulated kinase 1 (SGK1), transcript variant 3, mRNA. (from RefSeq NM_001143677)
SGK1 (ENST00000413996.7) at chr6:134169250-134175991 - Homo sapiens serum/glucocorticoid regulated kinase 1 (SGK1), transcript variant 4, mRNA. (from RefSeq NM_001143678)
SGK1 (ENST00000367858.9) at chr6:134169246-134318058 - Homo sapiens serum/glucocorticoid regulated kinase 1 (SGK1), transcript variant 2, mRNA. (from RefSeq NM_001143676)
SGK1 (ENST00000237305.11) at chr6:134169252-134174896 - Homo sapiens serum/glucocorticoid regulated kinase 1 (SGK1), transcript variant 1, mRNA. (from RefSeq NM_005627)
DAXX (ENST00000616312.1) at chr6_GL000251v2_alt:4730044-4734505 - Transcription corepressor known to repress  transcriptional potential of several sumoylated transcription  factors. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by  regulating the RING-finger E3 ligase MDM2 ubiquitination activity.  Under non-stress condition, in association with the  deubiquitinating USP7, prevents MDM2 self-ubiquitination and  enhances the intrinsic E3 ligase activity of MDM2 towards TP53,  thereby promoting TP53 ubiquitination and subsequent proteasomal  degradation. Upon DNA damage, its association with MDM2 and USP7  is disrupted, resulting in increased MDM2 autoubiquitination and  consequently, MDM2 degradation, which leads to TP53 stabilization.  Proposed to mediate activation of the JNK pathway and apoptosis  via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2.  Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6  and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in  lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may  not involve DAXX. Seems to regulate transcription in PML/POD/ND10  nuclear bodies together with PML and may influence TNFRSF6-  dependent apoptosis thereby. Down-regulates basal and activated  transcription. Seems to act as a transcriptional corepressor and  inhibits PAX3 and ETS1 through direct protein-protein interaction.  Modulates PAX5 activity. Its transcription repressor activity is  modulated by recruiting it to subnuclear compartments like the  nucleolus or PML/POD/ND10 nuclear bodies through interactions with  MCSR1 and PML, respectively. (from UniProt Q9UER7)
DAXX (ENST00000620164.4) at chr6:33318559-33323016 - Transcription corepressor known to repress  transcriptional potential of several sumoylated transcription  factors. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by  regulating the RING-finger E3 ligase MDM2 ubiquitination activity.  Under non-stress condition, in association with the  deubiquitinating USP7, prevents MDM2 self-ubiquitination and  enhances the intrinsic E3 ligase activity of MDM2 towards TP53,  thereby promoting TP53 ubiquitination and subsequent proteasomal  degradation. Upon DNA damage, its association with MDM2 and USP7  is disrupted, resulting in increased MDM2 autoubiquitination and  consequently, MDM2 degradation, which leads to TP53 stabilization.  Proposed to mediate activation of the JNK pathway and apoptosis  via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2.  Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6  and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in  lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may  not involve DAXX. Seems to regulate transcription in PML/POD/ND10  nuclear bodies together with PML and may influence TNFRSF6-  dependent apoptosis thereby. Down-regulates basal and activated  transcription. Seems to act as a transcriptional corepressor and  inhibits PAX3 and ETS1 through direct protein-protein interaction.  Modulates PAX5 activity. Its transcription repressor activity is  modulated by recruiting it to subnuclear compartments like the  nucleolus or PML/POD/ND10 nuclear bodies through interactions with  MCSR1 and PML, respectively. (from UniProt Q9UER7)
DAXX (ENST00000613912.3) at chr6_GL000252v2_alt:4562074-4566535 - Transcription corepressor known to repress  transcriptional potential of several sumoylated transcription  factors. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by  regulating the RING-finger E3 ligase MDM2 ubiquitination activity.  Under non-stress condition, in association with the  deubiquitinating USP7, prevents MDM2 self-ubiquitination and  enhances the intrinsic E3 ligase activity of MDM2 towards TP53,  thereby promoting TP53 ubiquitination and subsequent proteasomal  degradation. Upon DNA damage, its association with MDM2 and USP7  is disrupted, resulting in increased MDM2 autoubiquitination and  consequently, MDM2 degradation, which leads to TP53 stabilization.  Proposed to mediate activation of the JNK pathway and apoptosis  via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2.  Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6  and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in  lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may  not involve DAXX. Seems to regulate transcription in PML/POD/ND10  nuclear bodies together with PML and may influence TNFRSF6-  dependent apoptosis thereby. Down-regulates basal and activated  transcription. Seems to act as a transcriptional corepressor and  inhibits PAX3 and ETS1 through direct protein-protein interaction.  Modulates PAX5 activity. Its transcription repressor activity is  modulated by recruiting it to subnuclear compartments like the  nucleolus or PML/POD/ND10 nuclear bodies through interactions with  MCSR1 and PML, respectively. (from UniProt Q9UER7)
DAXX (ENST00000622655.1) at chr6_GL000254v2_alt:4754494-4758948 - Transcription corepressor known to repress  transcriptional potential of several sumoylated transcription  factors. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by  regulating the RING-finger E3 ligase MDM2 ubiquitination activity.  Under non-stress condition, in association with the  deubiquitinating USP7, prevents MDM2 self-ubiquitination and  enhances the intrinsic E3 ligase activity of MDM2 towards TP53,  thereby promoting TP53 ubiquitination and subsequent proteasomal  degradation. Upon DNA damage, its association with MDM2 and USP7  is disrupted, resulting in increased MDM2 autoubiquitination and  consequently, MDM2 degradation, which leads to TP53 stabilization.  Proposed to mediate activation of the JNK pathway and apoptosis  via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2.  Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6  and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in  lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may  not involve DAXX. Seems to regulate transcription in PML/POD/ND10  nuclear bodies together with PML and may influence TNFRSF6-  dependent apoptosis thereby. Down-regulates basal and activated  transcription. Seems to act as a transcriptional corepressor and  inhibits PAX3 and ETS1 through direct protein-protein interaction.  Modulates PAX5 activity. Its transcription repressor activity is  modulated by recruiting it to subnuclear compartments like the  nucleolus or PML/POD/ND10 nuclear bodies through interactions with  MCSR1 and PML, respectively. (from UniProt Q9UER7)
DAXX (ENST00000619421.1) at chr6_GL000255v2_alt:4512988-4517446 - Transcription corepressor known to repress  transcriptional potential of several sumoylated transcription  factors. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by  regulating the RING-finger E3 ligase MDM2 ubiquitination activity.  Under non-stress condition, in association with the  deubiquitinating USP7, prevents MDM2 self-ubiquitination and  enhances the intrinsic E3 ligase activity of MDM2 towards TP53,  thereby promoting TP53 ubiquitination and subsequent proteasomal  degradation. Upon DNA damage, its association with MDM2 and USP7  is disrupted, resulting in increased MDM2 autoubiquitination and  consequently, MDM2 degradation, which leads to TP53 stabilization.  Proposed to mediate activation of the JNK pathway and apoptosis  via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2.  Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6  and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in  lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may  not involve DAXX. Seems to regulate transcription in PML/POD/ND10  nuclear bodies together with PML and may influence TNFRSF6-  dependent apoptosis thereby. Down-regulates basal and activated  transcription. Seems to act as a transcriptional corepressor and  inhibits PAX3 and ETS1 through direct protein-protein interaction.  Modulates PAX5 activity. Its transcription repressor activity is  modulated by recruiting it to subnuclear compartments like the  nucleolus or PML/POD/ND10 nuclear bodies through interactions with  MCSR1 and PML, respectively. (from UniProt Q9UER7)
DAXX (ENST00000436311.6) at chr6_GL000251v2_alt:4730043-4734503 - Transcription corepressor known to repress  transcriptional potential of several sumoylated transcription  factors. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by  regulating the RING-finger E3 ligase MDM2 ubiquitination activity.  Under non-stress condition, in association with the  deubiquitinating USP7, prevents MDM2 self-ubiquitination and  enhances the intrinsic E3 ligase activity of MDM2 towards TP53,  thereby promoting TP53 ubiquitination and subsequent proteasomal  degradation. Upon DNA damage, its association with MDM2 and USP7  is disrupted, resulting in increased MDM2 autoubiquitination and  consequently, MDM2 degradation, which leads to TP53 stabilization.  Proposed to mediate activation of the JNK pathway and apoptosis  via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2.  Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6  and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in  lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may  not involve DAXX. Seems to regulate transcription in PML/POD/ND10  nuclear bodies together with PML and may influence TNFRSF6-  dependent apoptosis thereby. Down-regulates basal and activated  transcription. Seems to act as a transcriptional corepressor and  inhibits PAX3 and ETS1 through direct protein-protein interaction.  Modulates PAX5 activity. Its transcription repressor activity is  modulated by recruiting it to subnuclear compartments like the  nucleolus or PML/POD/ND10 nuclear bodies through interactions with  MCSR1 and PML, respectively. (from UniProt Q9UER7)
DAXX (ENST00000383062.8) at chr6_GL000252v2_alt:4562073-4566533 - Transcription corepressor known to repress  transcriptional potential of several sumoylated transcription  factors. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by  regulating the RING-finger E3 ligase MDM2 ubiquitination activity.  Under non-stress condition, in association with the  deubiquitinating USP7, prevents MDM2 self-ubiquitination and  enhances the intrinsic E3 ligase activity of MDM2 towards TP53,  thereby promoting TP53 ubiquitination and subsequent proteasomal  degradation. Upon DNA damage, its association with MDM2 and USP7  is disrupted, resulting in increased MDM2 autoubiquitination and  consequently, MDM2 degradation, which leads to TP53 stabilization.  Proposed to mediate activation of the JNK pathway and apoptosis  via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2.  Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6  and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in  lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may  not involve DAXX. Seems to regulate transcription in PML/POD/ND10  nuclear bodies together with PML and may influence TNFRSF6-  dependent apoptosis thereby. Down-regulates basal and activated  transcription. Seems to act as a transcriptional corepressor and  inhibits PAX3 and ETS1 through direct protein-protein interaction.  Modulates PAX5 activity. Its transcription repressor activity is  modulated by recruiting it to subnuclear compartments like the  nucleolus or PML/POD/ND10 nuclear bodies through interactions with  MCSR1 and PML, respectively. (from UniProt Q9UER7)
DAXX (ENST00000433482.5) at chr6_GL000254v2_alt:4754493-4758861 - Transcription corepressor known to repress  transcriptional potential of several sumoylated transcription  factors. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by  regulating the RING-finger E3 ligase MDM2 ubiquitination activity.  Under non-stress condition, in association with the  deubiquitinating USP7, prevents MDM2 self-ubiquitination and  enhances the intrinsic E3 ligase activity of MDM2 towards TP53,  thereby promoting TP53 ubiquitination and subsequent proteasomal  degradation. Upon DNA damage, its association with MDM2 and USP7  is disrupted, resulting in increased MDM2 autoubiquitination and  consequently, MDM2 degradation, which leads to TP53 stabilization.  Proposed to mediate activation of the JNK pathway and apoptosis  via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2.  Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6  and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in  lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may  not involve DAXX. Seems to regulate transcription in PML/POD/ND10  nuclear bodies together with PML and may influence TNFRSF6-  dependent apoptosis thereby. Down-regulates basal and activated  transcription. Seems to act as a transcriptional corepressor and  inhibits PAX3 and ETS1 through direct protein-protein interaction.  Modulates PAX5 activity. Its transcription repressor activity is  modulated by recruiting it to subnuclear compartments like the  nucleolus or PML/POD/ND10 nuclear bodies through interactions with  MCSR1 and PML, respectively. (from UniProt Q9UER7)
DAXX (ENST00000383194.8) at chr6_GL000255v2_alt:4512987-4517444 - Transcription corepressor known to repress  transcriptional potential of several sumoylated transcription  factors. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by  regulating the RING-finger E3 ligase MDM2 ubiquitination activity.  Under non-stress condition, in association with the  deubiquitinating USP7, prevents MDM2 self-ubiquitination and  enhances the intrinsic E3 ligase activity of MDM2 towards TP53,  thereby promoting TP53 ubiquitination and subsequent proteasomal  degradation. Upon DNA damage, its association with MDM2 and USP7  is disrupted, resulting in increased MDM2 autoubiquitination and  consequently, MDM2 degradation, which leads to TP53 stabilization.  Proposed to mediate activation of the JNK pathway and apoptosis  via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2.  Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6  and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in  lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may  not involve DAXX. Seems to regulate transcription in PML/POD/ND10  nuclear bodies together with PML and may influence TNFRSF6-  dependent apoptosis thereby. Down-regulates basal and activated  transcription. Seems to act as a transcriptional corepressor and  inhibits PAX3 and ETS1 through direct protein-protein interaction.  Modulates PAX5 activity. Its transcription repressor activity is  modulated by recruiting it to subnuclear compartments like the  nucleolus or PML/POD/ND10 nuclear bodies through interactions with  MCSR1 and PML, respectively. (from UniProt Q9UER7)
DAXX (ENST00000266000.10) at chr6:33318558-33323010 - Transcription corepressor known to repress  transcriptional potential of several sumoylated transcription  factors. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by  regulating the RING-finger E3 ligase MDM2 ubiquitination activity.  Under non-stress condition, in association with the  deubiquitinating USP7, prevents MDM2 self-ubiquitination and  enhances the intrinsic E3 ligase activity of MDM2 towards TP53,  thereby promoting TP53 ubiquitination and subsequent proteasomal  degradation. Upon DNA damage, its association with MDM2 and USP7  is disrupted, resulting in increased MDM2 autoubiquitination and  consequently, MDM2 degradation, which leads to TP53 stabilization.  Proposed to mediate activation of the JNK pathway and apoptosis  via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2.  Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6  and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in  lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may  not involve DAXX. Seems to regulate transcription in PML/POD/ND10  nuclear bodies together with PML and may influence TNFRSF6-  dependent apoptosis thereby. Down-regulates basal and activated  transcription. Seems to act as a transcriptional corepressor and  inhibits PAX3 and ETS1 through direct protein-protein interaction.  Modulates PAX5 activity. Its transcription repressor activity is  modulated by recruiting it to subnuclear compartments like the  nucleolus or PML/POD/ND10 nuclear bodies through interactions with  MCSR1 and PML, respectively. (from UniProt Q9UER7)
PRKCB (ENST00000643927.1) at chr16:23835983-24220611 - Homo sapiens protein kinase C beta (PRKCB), transcript variant 2, mRNA. (from RefSeq NM_002738)
PRKCB (ENST00000321728.12) at chr16:23835983-24220611 - Homo sapiens protein kinase C beta (PRKCB), transcript variant 1, mRNA. (from RefSeq NM_212535)
SLC2A4RG (ENST00000266077.5) at chr20:63739776-63744050 - Homo sapiens SLC2A4 regulator (SLC2A4RG), mRNA. (from RefSeq NM_020062)
SLC2A4RG (ENST00000496425.1) at chr20:63742528-63743117 - SLC2A4 regulator (from HGNC SLC2A4RG)
SLC2A4RG (ENST00000493772.5) at chr20:63741252-63743505 - SLC2A4 regulator (from HGNC SLC2A4RG)
SLC2A4RG (ENST00000491109.1) at chr20:63741404-63742534 - SLC2A4 regulator (from HGNC SLC2A4RG)
SLC2A4RG (ENST00000485897.5) at chr20:63740380-63742490 - SLC2A4 regulator (from HGNC SLC2A4RG)
SLC2A4RG (ENST00000482718.1) at chr20:63741922-63742535 - SLC2A4 regulator (from HGNC SLC2A4RG)
SLC2A4RG (ENST00000474248.5) at chr20:63740243-63742166 - SLC2A4 regulator (from HGNC SLC2A4RG)
SLC2A4RG (ENST00000473157.1) at chr20:63741915-63743505 - SLC2A4 regulator (from HGNC SLC2A4RG)
MEF2A (ENST00000449277.6) at chr15:99565990-99716406 - Homo sapiens myocyte enhancer factor 2A (MEF2A), transcript variant 4, mRNA. (from RefSeq NM_001130928)
MEF2A (ENST00000354410.9) at chr15:99565700-99716466 - Homo sapiens myocyte enhancer factor 2A (MEF2A), transcript variant 1, mRNA. (from RefSeq NM_005587)
MEF2A (ENST00000338042.10) at chr15:99565928-99716422 - Homo sapiens myocyte enhancer factor 2A (MEF2A), transcript variant 2, mRNA. (from RefSeq NM_001130926)
MEF2A (ENST00000558812.5) at chr15:99565928-99713324 - Homo sapiens myocyte enhancer factor 2A (MEF2A), transcript variant 20, mRNA. (from RefSeq NM_001365209)
MEF2A (ENST00000557942.5) at chr15:99566087-99716424 - Homo sapiens myocyte enhancer factor 2A (MEF2A), transcript variant 16, mRNA. (from RefSeq NM_001365205)
MEF2A (ENST00000557785.5) at chr15:99565980-99713782 - Homo sapiens myocyte enhancer factor 2A (MEF2A), transcript variant 19, mRNA. (from RefSeq NM_001365208)

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

NM_001042.3 at chr17:7281718-7288257
NM_020062.4 at chr20:63739776-63744050

NCBI RefSeq and Ensembl transcripts from the MANE Project (v0.6)

SLC2A4 at chr17:7281718-7288257
SLC2A4RG at chr20:63739776-63744050

RefSeq Genes

SLC2A4 at chr17:7281718-7288257 - (NM_001042) solute carrier family 2, facilitated glucose transporter member 4
SLC2A4RG at chr20:63739776-63744050 - (NM_020062) SLC2A4 regulator

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

trafficking regulator of GLUT4 (SLC2A4) 1 at chr17:1279662-1300978 - (NM_172367.3)
SLC2A4 regulator at chr20:63739776-63744050 - (NM_020062.4)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant 2 at chr17:81977629-82017406 - (NM_001251888.2)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant 4 at chr17:81977629-82017406 - (NM_001330528.2)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant 1 at chr17:81977629-82017406 - (NM_024083.4)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant 3 at chr17:81977629-82017406 - (NR_045351.2)

NCBI RefSeq genes, predicted subset (XM_* or XR_*)

ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X10 at chr17:81977634-82017582 - (XM_024450926.1)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X9 at chr17:81977550-82017406 - (XM_017025042.1)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X7 at chr17:81979184-82017669 - (XM_017025040.2)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X5 at chr17:81977602-82017669 - (XM_017025038.2)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X1 at chr17:81977550-82017648 - (XM_017025036.2)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X3 at chr17:81977550-82017582 - (XM_011523601.3)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X4 at chr17:81977550-82017580 - (XM_011523602.3)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X2 at chr17:81977550-82017645 - (XM_017025037.2)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X6 at chr17:81979184-82017669 - (XM_017025039.2)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X8 at chr17:81977634-82017669 - (XM_017025041.2)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X11 at chr17:81977602-82017406 - (XM_017025044.1)
ASPSCR1 tether for SLC2A4, UBX domain containing, transcript variant X12 at chr17:81977550-82017401 - (XR_001752618.2)

Non-Human RefSeq Genes

SLC2A4 at chr17:7281935-7287756 - (NM_001089313) solute carrier family 2, facilitated glucose transporter member 4
SLC2A4 at chr17:7281935-7286629 - (NM_001305197) solute carrier family 2, facilitated glucose transporter member 4
SLC2A4 at chr17:7281912-7286776 - (NM_001314227) solute carrier family 2, facilitated glucose transporter member 4
SLC2A4 at chr17:7281935-7286719 - (NM_001081866) solute carrier family 2, facilitated glucose transporter member 4
SLC2A4 at chr17:7281925-7287823 - (NM_001128433) solute carrier family 2, facilitated glucose transporter member 4
SLC2A4 at chr17:7281744-7287799 - (NM_001159327) solute carrier family 2, facilitated glucose transporter member 4
Slc2a4 at chr17:7281923-7287682 - (NM_012751) solute carrier family 2, facilitated glucose transporter member 4
Slc2a4 at chr17:7281923-7287824 - (NM_009204) solute carrier family 2, facilitated glucose transporter member 4 isoform 1
SLC2A4 at chr17:7281762-7287800 - (NM_174604) solute carrier family 2, facilitated glucose transporter member 4
Slc2a4 at chr17:7281923-7287824 - (NM_001359114) solute carrier family 2, facilitated glucose transporter member 4 isoform 2
slc2a4.L at chr17:7283269-7286539 - (NM_001092138) solute carrier family 2 (facilitated glucose transporter), member 4 L homeolog
slc2a4.L at chr1:42927608-42943306 - (NM_001092138) solute carrier family 2 (facilitated glucose transporter), member 4 L homeolog

Basic Gene Annotation Set from GENCODE Version 33 (Ensembl 99)

SLC2A4 at chr17:7281718-7288257
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7282130-7286167

Comprehensive Gene Annotation Set from GENCODE Version 33 (Ensembl 99)

SLC2A4 at chr17:7281718-7288257
SLC2A4 at chr17:7281735-7287833
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7281808-7286901
SLC2A4 at chr17:7282130-7286167

Basic Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7282130-7286167

Comprehensive Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281735-7287833
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7281808-7286901
SLC2A4 at chr17:7282130-7286167

Basic Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7282130-7286167

Comprehensive Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281735-7287833
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7281808-7286901
SLC2A4 at chr17:7282130-7286167

Basic Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7282130-7286167

Comprehensive Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281735-7287833
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7281808-7286901
SLC2A4 at chr17:7282130-7286167

Basic Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7282130-7286167

Comprehensive Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281735-7287833
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7281808-7286901
SLC2A4 at chr17:7282130-7286167

Basic Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7282130-7286167

Comprehensive Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281735-7287833
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7281808-7286901
SLC2A4 at chr17:7282130-7286167

Basic Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7282130-7286167

Comprehensive Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281735-7287833
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7281808-7286901
SLC2A4 at chr17:7282130-7286167

Basic Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7282130-7286167

Comprehensive Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281735-7287833
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7281808-7286901
SLC2A4 at chr17:7282130-7286167

Basic Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7282130-7286167

Comprehensive Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281735-7287833
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7281808-7286901
SLC2A4 at chr17:7282130-7286167

Basic Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7282130-7286167

Comprehensive Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281735-7287833
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7281808-7286901
SLC2A4 at chr17:7282130-7286167

Basic Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7282130-7286167

Comprehensive Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

SLC2A4 at chr17:7281667-7288257
SLC2A4 at chr17:7281735-7287833
SLC2A4 at chr17:7281736-7286151
SLC2A4 at chr17:7281808-7286901
SLC2A4 at chr17:7282130-7286167

International Knockout Mouse Consortium Genes Mapped to Human Genome

Slc2a4_45903 at chr17:7281735-7288048

Human Aligned mRNA Search Results

BC052306 - Homo sapiens SLC2A4 regulator, mRNA (cDNA clone MGC:59731 IMAGE:6576325), complete cds.
BC034387 - Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 4, mRNA (cDNA clone MGC:34545 IMAGE:5187454), complete cds.
BC001402 - Homo sapiens SLC2A4 regulator, mRNA (cDNA clone IMAGE:3140406), partial cds.
BC028349 - Homo sapiens SLC2A4 regulator, mRNA (cDNA clone IMAGE:3951740), partial cds.
BC069615 - Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 4, mRNA (cDNA clone MGC:97210 IMAGE:7262457), complete cds.
BC069621 - Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 4, mRNA (cDNA clone MGC:97221 IMAGE:7262469), complete cds.
BC113592 - Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 4, mRNA (cDNA clone MGC:142152 IMAGE:8322644), complete cds.
BC126164 - Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 4, mRNA (cDNA clone MGC:161442 IMAGE:8991880), complete cds.
AK298304 - Homo sapiens cDNA FLJ58270 complete cds, highly similar to SLC2A4 regulator.
AK313372 - Homo sapiens cDNA, FLJ93903, highly similar to Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 4 (SLC2A4), mRNA.

Non-Human Aligned mRNA Search Results

JP018206 - TSA: Mustela putorius furo MPF81013445contig1/2 mRNA sequence.
JP018207 - TSA: Mustela putorius furo MPF81013446contig2/2 mRNA sequence.
AB248266 - Suncus murinus Slc2a4 mRNA for Glut4, partial cds.
JN695651 - Artibeus jamaicensis solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695652 - Artibeus lituratus solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695653 - Cynopterus sphinx solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695654 - Eonycteris spelaea solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695655 - Hipposideros armiger solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695656 - Hipposideros pratti solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695657 - Leptonycteris yerbabuenae solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695658 - Mormoops megalophylla solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695659 - Myotis pilosus solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695660 - Pteropus vampyrus solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695661 - Rhinolophus ferrumequinum solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695662 - Rousettus leschenaultii solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695663 - Scotophilus kuhlii solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695664 - Tadarida brasiliensis solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
JN695665 - Taphozous melanopogon solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4) mRNA, complete cds.
BC014282 - Mus musculus solute carrier family 2 (facilitated glucose transporter), member 4, mRNA (cDNA clone MGC:13736 IMAGE:4207674), complete cds.
BC085757 - Rattus norvegicus solute carrier family 2 (facilitated glucose transporter), member 4, mRNA (cDNA clone MGC:93607 IMAGE:7192278), complete cds.
EU107803 - Phodopus sungorus solute carrier family 2 member 4 (Slc2a4) mRNA, partial cds.
EU076589 - Sus scrofa solute carrier family 2 member 4 (SLC2A4) mRNA, partial cds.
FJ490182 - Bos taurus solute carrier family 2 member 4 (SLC2A4) mRNA, partial cds.
FJ797639 - Canis lupus familiaris solute carrier family 2 (facilitated glucose transporter) member 4 (SLC2A4) mRNA, partial cds.
KX168424 - Camelus dromedarius breed Arabia solute carrier family 2 member 4 (SLC2A4) mRNA, complete cds.
BC114082 - Bos taurus solute carrier family 2 (facilitated glucose transporter), member 4, mRNA (cDNA clone MGC:137703 IMAGE:8175930), complete cds.
JT411555 - TSA: Ictalurus punctatus clc_472098 mRNA sequence.
EF102089 - Xenopus laevis solute carrier family 2, facilitated glucose transporter member 4 (SLC2A4) mRNA, complete cds.